SCHEMBL21419459

SCHEMBL21419459

CCOC(=O)CC(N)c1c(C(=O)c2ccc3c(c2)OCO3)[nH]c2ccccc12

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 4/20 0.56
▸ HPGD P15428 2/20 0.56
▸ KMT2A Q03164 7/20 0.45
▸ MEN1 O00255 6/20 0.45
▸ MAPT P10636 6/20 0.45
▸ TSHR P16473 4/20 0.45
▸ CYP1A2 P05177 3/20 0.45
▸ CYP3A4 P08684 3/20 0.45
▸ HSD17B10 Q99714 3/20 0.45
▸ CYP2D6 P10635 2/20 0.45
▸ CYP2C19 P33261 2/20 0.45
▸ CYP2C9 P11712 1/20 0.45
▸ ALOX12 P18054 1/20 0.45
▸ KDM4E B2RXH2 5/20 0.43
▸ ELANE P08246 1/20 0.43
▸ RAB9A P51151 4/20 0.41
▸ SMN1; SMN2 Q16637 2/20 0.41
▸ NPC1 O15118 2/20 0.41
▸ PKM P14618 1/20 0.41
▸ HCRTR1 O43613 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15384066 0.81 ALDH1A1 (0.57) ALDH1A1HPGDKMT2AMEN1MAPT
SCHEMBL23095240 0.74 HTT (0.53) ALDH1A1HPGDKMT2AMEN1MAPT
SCHEMBL8249411 0.72 RAB9A (0.50) ALDH1A1HPGDKMT2AMAPTTSHR
SCHEMBL15239118 0.72 RAB9A (0.50) ALDH1A1HPGDKMT2AMAPTTSHR
SCHEMBL3144643 0.72 RAB9A (0.50) ALDH1A1HPGDKMT2AMAPTTSHR
Hydrochloric Acid SCHEMBL4585660 0.71 RAB9A (0.49) ALDH1A1HPGDKMT2AMAPTTSHR
Hydrochloric Acid SCHEMBL131112 0.71 RAB9A (0.49) ALDH1A1HPGDKMT2AMAPTTSHR
SCHEMBL7929844 0.69 ALDH1A1 (0.49) ALDH1A1HPGDKMT2AMEN1MAPT
SCHEMBL7923355 0.69 ALDH1A1 (0.49) ALDH1A1HPGDKMT2AMEN1MAPT
SCHEMBL30951564 0.68 KMT2A (0.76) ALDH1A1HPGDKMT2AMEN1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10793836-B2 Engineered imine reductases and methods for the reductive amination of ketone and amine compounds CODEXIS, INC. (US) 2020-10-06 — — US disclosed
US-20190300865-A1 ENGINEERED IMINE REDUCTASES AND METHODS FOR THE REDUCTIVE AMINATION OF KETONE AND AMINE COMPOUNDS INNOVATUS LIFE SCIENCES LENDING FUND I, LP, AS COLLATERAL AGENT 2019-10-03 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10793836-B2 Engineered imine reductases and methods for the reductive amination of ketone and amine compounds AKR1C4, AKR7A2, AKR1C2 ALDH1A1 162/4885HPGD 216/4885KMT2A 1015/4885
US-20190300865-A1 ENGINEERED IMINE REDUCTASES AND METHODS FOR THE REDUCTIVE AMINATION OF KETONE AND AMINE COMPOUNDS AKR1C4, AKR7A2, AKR1C2 ALDH1A1 162/4885HPGD 216/4885KMT2A 1015/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback